No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Galderma’s Ph III Nemolizumab Trials Show Positive Results in Atopic Dermatitis
On 25 July 2024, Galderma announced that results from its Phase III trials on nemolizumab, published in The Lancet, demonstrate statistically and clinically significant improvements in inflammation and itch in moderate to severe atopic dermatitis. The studies...